Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Linhao Xie
Silencing of CXCR4 Sensitizes Triple-Negative Breast Cancer Cells to Cisplatin
Oncotarget
Oncology
Related publications
ISL1 Promotes Cancer Progression and Inhibits Cisplatin Sensitivity in Triple-Negative Breast Cancer Cells
International Journal of Molecular Medicine
Medicine
Genetics
Cisplatin Loaded Multiwalled Carbon Nanotubes Induce Resistance in Triple Negative Breast Cancer Cells
Pharmaceutics
Pharmaceutical Science
Retraction Note To: Suppression of the xCT–CD44v Antiporter System Sensitizes Triple-Negative Breast Cancer Cells to Doxorubicin
Breast Cancer Research and Treatment
Cancer Research
Oncology
CXCR4 Inhibitors Could Benefit to HER2 but Not to Triple-Negative Breast Cancer Patients
Oncogene
Cancer Research
Genetics
Molecular Biology
FZD7 in Triple Negative Breast Cancer Cells
Silencing the Roadblocks to Effective Triple-Negative Breast Cancer Treatments by siRNA Nanoparticles
Endocrine-Related Cancer
Cancer Research
Endocrinology
Oncology
Metabolism
Diabetes
Blockage of Cisplatin-Induced Autophagy Sensitizes Cervical Cancer Cells to Cisplatin
Genetics and Molecular Research
Medicine
Genetics
Molecular Biology
Silencing of Casein Kinase 1 Delta Reduces Migration and Metastasis of Triple Negative Breast Cancer Cells
Oncotarget
Oncology
Dasatinib Sensitises Triple Negative Breast Cancer Cells to Chemotherapy by Targeting Breast Cancer Stem Cells
British Journal of Cancer
Cancer Research
Oncology